학술논문
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study
Document Type
article
Author
Angelina K. C. Fink; Amanda C. DeRenzis; Shivanshu Awasthi; Nawreen Jahan; Peter A. S. Johnstone; Julio Pow‐Sang; Javier Torres‐Roca; Daniel Grass; Daniel Fernandez; Arash Naghavi; Susan Tan; Brandon Manley; Roger Li; Michael Poch; Alice Yu; Nikki Little; Eppie Bass; Cesar E. Ercole; Evangelia Katsoulakis; Ryan Burri; Riley Smith; Nathanael B. Stanley; Susan T. Vadaparampil; Kosj Yamoah
Source
Cancer Medicine, Vol 12, Iss 2, Pp 1869-1877 (2023)
Subject
Language
English
ISSN
2045-7634
Abstract
Abstract Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing and retaining minority patients into clinical trials. This study sought to identify and address barriers to minority accrual to a minimal risk clinical research study in real‐time.